Hyperdynamic circulation in cirrhosis: predictive factors and outcome following liver transplantation

A Siniscalchi1, L Aurini, S Spedicato

  • 1Department of Anesthesiology, Alma Mater Studiorum-University of Bologna, Bologna, Italy. sinianest@libero.it

Minerva Anestesiologica
|October 24, 2012
PubMed

Insights

Hyperdynamic circulation (HC) in liver cirrhosis patients undergoing liver transplantation is predicted by MELD score and beta-blocker use. HC impacts intraoperative hemodynamics and increases mortality risk.

Area of Science:

  • Hepatology
  • Transplantation Medicine
  • Critical Care Medicine

Background:

  • Liver cirrhosis is characterized by a hyperdynamic circulation (HC).
  • Understanding HC is crucial for managing cirrhotic patients undergoing orthotopic liver transplantation (OLT).

Purpose of the Study:

  • Investigate predictive factors of HC in OLT patients.
  • Assess HC's impact on intraoperative hemodynamics and postoperative outcomes.
  • Evaluate HC's association with early ICU and in-hospital mortality.

Main Methods:

  • Observational study of 242 patients undergoing cadaveric OLT.
  • Hemodynamic parameters assessed using a pulmonary artery catheter.
  • Patients categorized based on systemic vascular resistance (SVR).

Main Results:

  • 33% of patients presented with severe HC.
  • MELD score and beta-blocker use were significant predictors of HC.
  • Beta-blocker use was associated with a lower incidence of HC.

Conclusions:

  • MELD score independently predicts HC in OLT patients.
  • Beta-blockers are associated with reduced HC incidence.
  • Intraoperative HC is linked to hemodynamic instability and increased mortality risk.
Abstract

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...